{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/headache-medication-overuse/diagnosis/clinical-features/","result":{"pageContext":{"chapter":{"id":"c264e53b-3cbc-5157-819e-b2829d10ddf3","slug":"clinical-features","fullItemName":"Clinical features","depth":2,"htmlHeader":"<!-- begin field 783cb9c9-b0ae-417a-ba6e-5fb842dc0622 --><h2>When should I suspect medication overuse headache?</h2><!-- end field 783cb9c9-b0ae-417a-ba6e-5fb842dc0622 -->","summary":"","htmlStringContent":"<!-- begin item 4655fa3d-c1f3-4181-88bd-7af56ee8bc9f --><!-- begin field 1bd64ccb-3aa3-480f-82b8-494fac02a6ab --><ul><li>Medication overuse headache (MOH) should be suspected if headache develops or worsens in a person who is taking acute and/or symptomatic medications for treatment of a previously diagnosed primary headache disorder:</li><li><strong>The International Classification of Headache Disorders (ICHD) includes the following diagnostic criteria for medication overuse headache: </strong><ul><li>Headache occurring on 15 or more days per month in a patient with a pre-existing headache disorder <em>and</em></li><li>Regular overuse for more than 3 months of one or more drugs that can be taken for acute and/or symptomatic treatment of headache.<ul><li>For ergotamine, triptans, opioids and combination analgesics intake must be 10 days or more per month to be considered overuse.</li><li>For simple analgesics such as nonsteroidal anti-inflammatories (including aspirin) and paracetamol intake must be 15 days or more per month to be considered overuse.</li></ul></li><li>The headache must not be better accounted for by another ICHD diagnosis.</li></ul></li></ul><!-- end field 1bd64ccb-3aa3-480f-82b8-494fac02a6ab --><!-- end item 4655fa3d-c1f3-4181-88bd-7af56ee8bc9f -->","topic":{"id":"c3e2af9a-7e39-5197-9eb3-1ed7a0e55408","topicId":"876b21f6-c785-4745-8233-2a56adca5e2f","topicName":"Headache - medication overuse","slug":"headache-medication-overuse","lastRevised":"Last revised in NovemberÂ 2017","chapters":[{"id":"40857afc-808e-588e-8df4-4d8b15ec657a","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"63871d8d-20ed-5111-b909-c671b7d8290d","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"9cae9867-86cc-59c4-b6bf-f373dcba4164","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"8249aff5-50e4-5d82-9408-80a413334b35","slug":"changes","fullItemName":"Changes"},{"id":"db547c32-5bee-554a-a0b2-dc3586cf0545","slug":"update","fullItemName":"Update"}]},{"id":"2abe896d-4027-5ea6-b53c-4126bd2728c4","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"38f0d3b1-709d-5342-b729-a1341e432308","slug":"goals","fullItemName":"Goals"},{"id":"a38c1ab1-09de-5ef7-baff-841d15605039","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"43907ef2-b709-5ebe-b83b-ab23bc9ed6ca","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"0feb34c0-feb0-5b65-a4c1-32baeee2a780","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"dd0c4d51-1d5a-5ed5-913d-c4891dbdcdad","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"5b6a60a6-ec80-5422-af6f-b6397fc4eb49","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"3cd81fd7-0d7a-552d-84fc-71226d45fd89","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"3d866153-0662-5ce8-b955-3970472be336","slug":"definition","fullItemName":"Definition"},{"id":"d33eb885-20a8-5803-a999-aceb7adffb72","slug":"causes","fullItemName":"Causes"},{"id":"f8475e5f-a2f9-5002-932a-d7ba4870aa9f","slug":"prevalence","fullItemName":"Prevalence"},{"id":"a1c40b6b-4520-56e8-b2fa-bb765751e34f","slug":"prognosis","fullItemName":"Prognosis"}]},{"id":"b50624f5-1fc7-5aae-8abf-9c5d20c25996","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"c264e53b-3cbc-5157-819e-b2829d10ddf3","slug":"clinical-features","fullItemName":"Clinical features"},{"id":"7a8b4459-1ea1-567d-894f-eee914a8f3e0","slug":"assessment","fullItemName":"Assessment"},{"id":"0fffe194-2a62-5cc8-921c-70edbfaaee2f","slug":"differential-diagnosis","fullItemName":"Differential diagnosis"}]},{"id":"24bded00-bd1c-5e35-8d9e-e9cbdb170491","fullItemName":"Management","slug":"management","subChapters":[{"id":"5aa2d427-7d2b-5110-b3c3-149b3c9ae20f","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"2d1b86f8-d377-5c3d-9334-138f4cdb5622","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"e8ea0b38-7c95-5427-8107-b6506325dd95","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"83630e7e-e220-5043-af84-8cf6a05f13d4","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"9d829e6b-790e-5c8c-b792-58adea1a2dd3","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"7de26ebd-eda1-5880-8547-e657d94fc6a0","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"e74b3fd8-6eac-5d2e-886c-97583955d536","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"3ce1ab25-89c2-5795-9e6a-493771574210","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"78c55256-334c-5f3e-8d0f-80013fc16bc9","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"b50624f5-1fc7-5aae-8abf-9c5d20c25996","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"952e8ef7-7aac-5020-bb71-9074c778213b","slug":"basis-for-recommendation-d3b","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field 69e051c6-3ecb-49b6-a679-e456d251ea45 --><h3>Basis for recommendation</h3><!-- end field 69e051c6-3ecb-49b6-a679-e456d251ea45 -->","summary":null,"htmlStringContent":"<!-- begin item d3b86301-3bab-4e4d-b8b4-30b6fb7467a4 --><!-- begin field cc2aa6c8-46a5-4d73-be20-dc382bc12717 --><p>The information on the clinical features of medication overuse headache is based on the clinical guidelines <em>Guidelines for all healthcare professionals in the diagnosis and management of migraine, tension-type, cluster and medication-overuse headache</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-medication-overuse/references/\">BASH, 2010</a>]<em>, Headaches in over 12s: diagnosis and management (updated November 2015)</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-medication-overuse/references/\">NICE, 2012</a>], <em>The International Classification of Headache Disorders, 3rd edition (beta version)</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-medication-overuse/references/\">IHS, 2013</a>], and <em>Guideline for primary care management of headache in adults</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-medication-overuse/references/\">Becker, 2015</a>] and expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-medication-overuse/references/\">Johnson, 2013</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/headache-medication-overuse/references/\">Kristoffersen, 2014a</a>].</p><!-- end field cc2aa6c8-46a5-4d73-be20-dc382bc12717 --><!-- end item d3b86301-3bab-4e4d-b8b4-30b6fb7467a4 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}